What is Veerhealth Care Ltd (NIYATILEAS) share price return in the past 10 years?

Veerhealth Care Ltd share price has appreciated 14.4% annually (CAGR) over the past ten years.

What is the share price of Veerhealth Care Ltd (NIYATILEAS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Veerhealth Care Ltd (NIYATILEAS) on 02-Jul-2026 16:59:59 at 16:59 is 32.47.

What is the P/E ratio of Veerhealth Care?

The latest standalone P/E ratio of Veerhealth Care as of 02-Jul-2026 is 119.15.

What is the P/B ratio of Veerhealth Care Ltd (NIYATILEAS)?

The latest standalone P/B ratio of Veerhealth Care Ltd (NIYATILEAS) as of 02-Jul-2026 is 2.83.

What is the 52-week high and low of Veerhealth Care Ltd (NIYATILEAS)?

The 52-week high of Veerhealth Care Ltd (NIYATILEAS) is Rs. 32.58 and the 52-week low is Rs. 16.70.

Veerhealth Care Ltd (NIYATILEAS) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Veerhealth Care Ltd (NIYATILEAS)
Brand: Veerhealth Care

Veerhealth Care Ltd (NIYATILEAS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 511523 NSE: NIYATILEAS Trading | Small Cap | Veerhealth Care Share Price

Veerhealth Care Ltd (NIYATILEAS)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 511523 NSE: NIYATILEAS Trading | Small Cap | Veerhealth Care Share Price

Key Metrics

Valuation Multiples

Market Cap

₹65 Cr.

Current Price

₹32.5

52-Week Low / High

₹17 / 33

TTM EPS

₹0.3

TTM Sales

₹32.5 Cr.

Book Value per Share

₹11.5

P/E Ratio

119.15

Higher than its 5-year historical median

Industry PE

38.7

Price to Book (P/B)

2.83

Higher than its 5-year historical median

Price to Sales (P/S)

2.00

In line with its 5-year historical median

EV/EBITDA

21.17

Higher than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

1.78%

Underperforms industry median

Return on Capital Employed (ROCE)

3.15%

Underperforms industry median

Return on Assets (ROA)

1.26%

Operating Profit Margin

2.8%

Net Profit Margin

2.35%

Gross Profit Margin

8.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

26.1%

Operating Profit Growth (1 Year)

-24.59%

Net Profit Growth (1 Year)

-4.88%

Asset Quality

Promoter Holding

31.50%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹3 Cr.

Equity

₹20 Cr.

Face Value

₹10

All Time Low / High

₹0.25 / 43.75

Veerhealth Care stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Veerhealth Care Ltd a good quality company?

Veerhealth Care Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Veerhealth Care Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Veerhealth Care Ltd vs industry peers?

Veerhealth Care Ltd revenue CAGR is 7.28%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Veerhealth Care Ltd?

Promoters hold 31.50% of the Veerhealth Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Veerhealth Care Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 13% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	1.1%	1%	2.4%	2.9%	5.5%	5%	2.2%	6.3%	6%	3.2%	-
Value Creation Index ⓘ	-0.9	-0.9	-0.8	-0.8	-0.6	-0.7	-0.9	-0.6	-0.6	-0.8	-
Growth Parameters ⓘ
Sales ⓘ	2.1	1.9	5.2	6	11.7	10.6	9.6	13.3	13.2	16.7	32
Sales YoY Gr.	-	-9.4%	169.3%	15.7%	96.2%	-9.8%	-9%	37.8%	-0.4%	26.1%	-
Adj EPS ⓘ	0	0	0.1	0.1	0.2	0.3	-0.1	0.8	0.2	0.2	0.3
YoY Gr.	-	100%	400%	10%	109.1%	17.4%	-118.5%	NA	-74.7%	0%	-
BVPS (₹) ⓘ	9.2	9.3	9.5	9.6	9.9	10.1	10.1	10.7	10.9	11.1	11.5
Adj Net Profit ⓘ	0	0	0.1	0.2	0.3	0.4	-0.1	1.6	0.4	0.4	1
Cash Flow from Ops. ⓘ	-0	1.7	1.8	2	-0.4	1	1.8	-0.7	2.9	-0.4	-
Debt/CF from Ops. ⓘ	-3604	-0.1	0.7	0.5	-7	1.7	0	0	0	-12.5	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	25.8%	7.3%	20.1%	26.1%
Adj EPS ⓘ	39.5%	-2.8%	NA	0%
BVPSⓘ	2.1%	2.3%	3.4%	1.7%
Share Price	14.4%	45.9%	26.7%	57.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.1	0.2	1.1	1.2	2.4	2.7	-0.5	9	1.9	1.8	2.4
Op. Profit Mgn % ⓘ	-1	-18.9	-2.4	7.4	5.8	-0.6	-8.6	3.7	4.6	2.8	7.6
Net Profit Mgn % ⓘ	0.4	1.2	2.7	2.6	2.7	3.6	-0.8	11.9	3.1	2.4	1.7
Debt to Equity ⓘ	0.1	-0	0.1	0.1	0.2	0.1	0	0	0	0.2	0.2
Working Cap Days ⓘ	1,943	2,072	685	525	262	305	348	259	353	313	64
Cash Conv. Cycle ⓘ	274	374	125	42	18	64	75	71	90	68	29

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2.12	1.92	5.17	5.98	11.73	10.58	9.63	13.27	13.22	16.67
Operating Expenses ⓘ +	2.14	2.28	5.29	5.54	11.05	10.64	10.46	12.78	12.61	16.21
Manufacturing Costs	0.10	0.12	0.19	0.18	0.93	1.31	0.93	0.61	0.46	1.07
Material Costs	0.92	1.16	3.68	3.79	7.88	7.52	6.92	9.23	9.13	11.40
Employee Cost	0.47	0.58	0.57	0.47	0.80	0.83	0.88	0.90	1.31	1.58
Other Costs ⓘ	0.66	0.42	0.85	1.11	1.44	0.99	1.73	2.04	1.72	2.16
Operating Profit ⓘ	-0.02	-0.36	-0.12	0.44	0.68	-0.06	-0.83	0.49	0.61	0.46
Operating Profit Margin (%)	-1.0%	-18.9%	-2.4%	7.4%	5.8%	-0.6%	-8.6%	3.7%	4.6%	2.8%
Other Income ⓘ +	0.38	0.72	0.72	0.29	0.48	1.33	1.68	1.25	1.39	1.22
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.13	0.10	0.07	0.03	0.19	0.22	0.09	0	0.01	0.26
Depreciation ⓘ	0.21	0.23	0.27	0.32	0.32	0.47	0.52	0.62	0.71	0.91
Profit Before Tax ⓘ	0.02	0.03	0.25	0.38	0.65	0.58	0.24	1.12	1.28	0.51
Tax ⓘ	0.01	0.01	0.11	0.22	0.33	0.20	0.31	-0.47	0.88	0.12
Profit After Tax	0.01	0.02	0.14	0.16	0.32	0.38	-0.07	1.58	0.41	0.39
PAT Margin (%)	0.4%	1.2%	2.7%	2.6%	2.7%	3.6%	-0.8%	11.9%	3.1%	2.4%
Adjusted EPS (₹)	0.0	0.0	0.1	0.1	0.2	0.3	-0.1	0.8	0.2	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Veerhealth Care - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	12.82	12.85	13.10	13.28	13.76	14.04	13.95	21.43	21.84	22.22
Share Capital ⓘ	6.93	6.93	6.93	6.93	6.93	6.93	6.93	10	20	20
Reserves ⓘ	5.88	5.92	6.17	6.35	6.82	7.11	7.02	11.43	1.84	2.22
Debt +	1.08	-0.17	1.21	0.94	2.48	1.73	0	0	0	4.91
Long Term Debt	0.67	0.44	0.21	0	2.04	1.41	0	0	0	4.20
Short Term Debt	0.41	-0.61	1.01	0.94	0.44	0.32	0	0	0	0.71
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.08	0.22	0.19	1.57	0.84	0.92	2.32	0.55	2.16	2.62
Others Liabilities ⓘ	0.14	0.16	0.23	0.36	0.91	2.04	3.88	3.27	4.12	4.02
Total Liabilities ⓘ	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25	28.12	33.77
Fixed Assets
Net Fixed Assets ⓘ +	2.71	2.52	5.54	5.46	9.45	9.48	10.54	12.01	11.97	19.87
Gross Block	3.07	3.11	6.41	6.62	10.88	11.37	12.96	15.05	16.03	24.84
Accumulated Depreciation	0.36	0.59	0.86	1.16	1.43	1.89	2.42	3.04	4.06	4.97
CWIP ⓘ	0	0	0.24	2.19	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0.03
Inventories	1.12	1.53	0.94	0.84	1.23	1.66	2.12	2.61	1.40	2.44
Trade Receivables	0.89	0.61	0.92	0.74	0.94	1.54	1.54	1.84	3.92	3.21
Cash Equivalents	0.10	0.02	0.08	0.18	0.02	0.10	0.40	3.61	0.24	1.16
Others Assets ⓘ	9.30	8.37	7.02	6.75	6.35	5.94	5.54	5.19	10.59	7.05
Total Assets ⓘ	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25	28.12	33.77

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	1.69	1.76	1.98	-0.36	1	1.81	-0.70	2.90	-0.39
PBT ⓘ	0.02	0.03	0.25	0.38	0.65	0.47	0.26	1.05	1.29	0.62
Adjustment ⓘ	-0.27	-0.07	-0.09	0.32	0.21	0.37	0.10	0.53	0.47	0.73
Changes in Working Capital ⓘ	0.24	0.95	1.7	1.41	-1.15	0.39	1.49	-2.08	1.42	-1.65
Tax Paid ⓘ	0	0.78	-0.10	-0.13	-0.06	-0.23	-0.04	-0.20	-0.28	-0.09
Cash Flow From Investing Activity ⓘ +	-0.01	-0.44	-3.02	-1.90	-1.67	-0.09	-1.09	-1.79	-0.28	-8.20
Capex	-0.76	-0.03	-3.54	-2.19	-2.12	-0.50	-1.58	-2.09	-0.67	-8.81
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.75	-0.40	0.52	0.29	0.46	0.41	0.49	0.30	0.40	0.61
Cash Flow From Financing Activity ⓘ +	0	-1.33	1.31	0.02	1.85	-0.83	-0.42	5.69	-5.99	9.52
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	5.90	0	0
Net Proceeds from Borrowing ⓘ	0	-0.21	-0.23	-0.21	2.04	-0.63	-1.41	0	0	4.20
Interest Paid ⓘ	0	-0.10	-0.07	-0.03	-0.19	-0.22	-0.09	-0.14	-0.16	-0.44
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-1.02	1.62	0.27	0	0.02	1.08	-0.06	-5.83	5.76
Net Cash Flow ⓘ	-0.01	-0.08	0.06	0.10	-0.17	0.09	0.30	3.21	-3.37	0.92

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.07	0.18	1.06	1.2	2.35	2.73	-0.53	8.94	1.88	1.78
ROCE (%)	1.13	1	2.38	2.89	5.5	4.97	2.17	6.32	5.96	3.15
Asset Turnover Ratio	0.15	0.14	0.37	0.39	0.69	0.58	0.5	0.58	0.5	0.54
PAT to CFO Conversion(x)	-0	84.5	12.57	12.38	-1.13	2.63	N/A	-0.44	7.07	-1
Working Capital Days
Receivable Days	152.40	142.10	53.90	50.70	26.10	42.80	58.50	46.50	79.50	78
Inventory Days	133.20	252.50	87.40	54.30	32.20	49.90	71.80	65	55.20	42.10
Payable Days	37.30	46.60	20.10	84.80	55.80	42.60	85.30	56.80	54.20	76.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Veerhealth Care Ltd FAQs

The current trading price of Veerhealth Care on 02-Jul-2026 16:59 is ₹32.47.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Veerhealth Care stood at ₹64.94 Cr

The latest P/E ratio of Veerhealth Care as of 01-Jul-2026 is 119.2.

The latest P/B ratio of Veerhealth Care as of 01-Jul-2026 is 2.83.

The 52-week high of Veerhealth Care is ₹32.58 and the 52-week low is ₹16.70.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Veerhealth Care is ₹32.48 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Veerhealth Care Ltd is a below average quality company.

The key valuation ratios of Veerhealth Care Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Veerhealth Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Veerhealth Care Ltd

Veerhealth Care (Formerly known as Niyati Industries) was originally incorporated on July 10, 1992 as Niyati Leasing Limited. From July 15, 1993 the Company had begun the business in the field of Investment and Finance.

In 2013, the management of the company decided to diversify the business activities and changed its main object to Pharma sector and new name of the company is VeerHealth Care. In 2020, the company started operations in cosmetic manufacturing.

The company produces Intensive research based quality products with Expert guidance and enormous experience of renowned Vaid of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic practioner since 30 years and Dr. Rajiv Bhirud, anexpert in formulations of cosmetic and personal care products.

The company is well-equipped with state-of-the-art manufacturing facilities and skilled personnel to ensure optimum utilization of resources with the best quality product.

Business area of the company

The company is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines.

Products of the company

Skincare
Bodycare
Haircare
Fragrances
Healthcare
Oralcare
Mens Care
Gifting
Combos
Accessories

Certifications

Ayurvedic Mfg Lic
Ayurvedic Gmp
Cosmetic Mfg Lic
Cosmetic Gmp
ISO 9001:2015
AEO Certificate

Veerhealth Care Ltd (NIYATILEAS)

Veerhealth Care Ltd (NIYATILEAS)

Veerhealth Care stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Veerhealth Care - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Veerhealth Care Ltd FAQs

About Veerhealth Care Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Veerhealth Care Ltd (NIYATILEAS)

Veerhealth Care Ltd (NIYATILEAS)

Veerhealth Care stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Veerhealth Care - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Veerhealth Care Ltd FAQs

What is the share price of Veerhealth Care?

What is the market cap of Veerhealth Care?

What is the P/E ratio of Veerhealth Care?

What is the P/B ratio of Veerhealth Care?

What is the 52-week high and low of Veerhealth Care?

What is the TTM revenue of Veerhealth Care?

Is Veerhealth Care Ltd a good quality company?

Is Veerhealth Care Ltd undervalued or overvalued?

Is Veerhealth Care Ltd a good buy now?

About Veerhealth Care Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.